These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 16501108
1. RNase L plays a role in the antiviral response to West Nile virus. Scherbik SV, Paranjape JM, Stockman BM, Silverman RH, Brinton MA. J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108 [Abstract] [Full Text] [Related]
2. RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype. Madden JC, Cui D, Brinton MA. J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462564 [Abstract] [Full Text] [Related]
8. Differential induction of antiviral effects against West Nile virus in primary mouse macrophages derived from flavivirus-susceptible and congenic resistant mice by alpha/beta interferon and poly(I-C). Pantelic L, Sivakumaran H, Urosevic N. J Virol; 2005 Feb 25; 79(3):1753-64. PubMed ID: 15650200 [Abstract] [Full Text] [Related]
9. Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon. Birdwell LD, Zalinger ZB, Li Y, Wright PW, Elliott R, Rose KM, Silverman RH, Weiss SR. J Virol; 2016 Jan 06; 90(6):3160-72. PubMed ID: 26739051 [Abstract] [Full Text] [Related]
10. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BR, Silverman RH, Gale M, Diamond MS. J Virol; 2006 Jul 06; 80(14):7009-19. PubMed ID: 16809306 [Abstract] [Full Text] [Related]